Last updated: March 24, 2025
Sponsor: NYU Langone Health
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congestive Heart Failure
Chest Pain
Hyponatremia
Treatment
AirOk Air Purifier
Placebo Air Filter
Clinical Study ID
NCT05230784
21-00954
R01ES033222
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adults ≥ 18 years of age diagnosed with HF with a reduced ejection fraction of ≤ 40%within the last six months in NYHA class II-IV.
Exclusion
Exclusion Criteria:
listed for a cardiac transplant
history of CRT device implantation in last 3 months
on oxygen therapy
with severe pulmonary disease
participants unable to ambulate
Study Design
Total Participants: 600
Treatment Group(s): 2
Primary Treatment: AirOk Air Purifier
Phase:
Study Start date:
March 06, 2024
Estimated Completion Date:
April 30, 2026
Connect with a study center
Centre for Chronic Disease Control (CCDC)
Thiruvananthapuram, Kerala
IndiaActive - Recruiting
All India Institute of Medical Sciences (AIIMS)
Delhi, Punjab
IndiaActive - Recruiting
Public Health Foundation of India (PHFI)
Ludhiāna, Punjab
IndiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.